defactinib and Multiple-Myeloma

defactinib has been researched along with Multiple-Myeloma* in 1 studies

Other Studies

1 other study(ies) available for defactinib and Multiple-Myeloma

ArticleYear
PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma.
    Haematologica, 2019, Volume: 104, Issue:7

    Topics: Aminopyridines; Benzamides; Drug Resistance, Neoplasm; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Humans; Hypoxia; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Sulfonamides; Tumor Cells, Cultured

2019